Search Results - "Verdirame, J D"

Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry by Gross, T G, Filipovich, A H, Conley, M E, Pracher, E, Schmiegelow, K, Verdirame, J D, Vowels, M, Williams, L L, Seemayer, T A

“…Seven male patients in the David T Purtilo International X-linked Lymphoproliferative Disease (XLP) Registry have undergone allogeneic hematopoietic stem cell…”
Get more information

Bone Marrow Transplantation for Peripheral T-Cell Lymphoma in Children and Adolescents by Gordon, Bruce G., Warkentin, Phyllis I., Weisenburger, Dennis D., Vose, Julie M., Sanger, Warren G., Strandjord, Sarah E., Anderson, James R., Verdirame, Joseph D., Bierman, Philip J., Armitage, James O., Coccia, Peter F.

“…We report nine children with relapsed (n = 8) or high-risk (n = 1) peripheral T-cell lymphoma (PTCL) who underwent autologous (n = 6) or allogeneic (n = 3)…”
Get full text

Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin by Alter, R, Joshi, S S, Verdirame, J D, Weisenburger, D D

“…A 58-year old male with follicular small cleaved B cell lymphoma developed pure red cell aplasia (PRCA) during chemotherapy. To understand the etiology of the…”
Get more information

The effect of radiographic contrast agents on bleeding time and platelet aggregation by Verdirame, J D, Davis, J W, Phillips, P E

“…The purpose of this study was to determine whether the use of relatively small amounts of radiographic contrast agents may impair hemostasis. Before and after…”
Get more information

Multiple myeloma associated with immune thrombocytopenic purpura by Verdirame, J D, Feagler, J R, Commers, J R

“…Thrombocytopenia in patients with multiple myeloma is usually due to chemotherapy or marrow replacement with myeloma cells. Two patients with multiple myeloma…”
Get more information

Bone marrow transplantation for good-risk patients with leukemia in a university affiliated hospital by Verdirame, J D, Bruckman, J E, Feagler, J R, Commers, J R

“…Of the first 14 patients with acute or chronic leukemia to undergo bone marrow transplantation at our hospital, 9 (64%), all good-risk, are still alive in…”
Get more information

Heterogeneity of pathogenetic mechanisms in aplastic anemia. Efficacy of therapy based on in-vitro results by Abdou, N I, Verdirame, J D, Amare, M, Abdou, N L

“…The mechanisms responsible for the bone marrow failure in 21 aplastic anemia patients were studied by the colony-forming units in culture assay (CFU-C). Twelve…”
Get more information

A placebo-controlled trial of etanercept, a tumor necrosis factor (TNF) inhibitor, in patients with the cancer anorexia/weight loss syndrome. North Central Cancer Treatment Group (NCCTG) trial N00C1 by Jatoi, A., Dakhil, S. R., Kugler, J. W., Rowland, K. M., Keit, J., Verdirame, J. D., Novotny, P. J., Sloan, J. A., Nguyen, P. L., Loprinzi, C. L.

“…Abstract only 8534 Purpose: Tumor necrosis factor (TNF) is a putative mediator of the cancer anorexia/weight loss syndrome. This study was designed to…”
Get full text

The non-Hodgkin's lymphomas: a review by Verdirame, J D

Get more information

Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents by Gordon, BG, Warkentin, PI, Weisenburger, DD, Vose, JM, Sanger, WG, Strandjord, SE, Anderson, JR, Verdirame, JD, Bierman, PJ, Armitage, JO

“…We report nine children with relapsed (n = 8) or high-risk (n = 1) peripheral T-cell lymphoma (PTCL) who underwent autologous (n = 6) or allogeneic (n = 3)…”
Get full text